Home
Reig Jofre logo
Reig Jofre

Reig Jofre

1.2K
85
27
3.7(12)

About Company

  • Legal Name: Reig Jofre
  • Registered country: Spain
  • Address: PADRE CLARET, 7, Madrid
  • Number of employees: 1000 - 4999
Description:

Founded in 1929 in Barcelona, Spain, REIG JOFRE is a pharmaceutical company listed on the Spanish Stock Exchange under the ticker RJF, dedicated to researching, developing, manufacturing and marketing pharmaceutical products and food supplements. The company has more than 1,100 employees, 4 development and production centers in Europe (2 in Toledo, 1 in Barcelona and 1 in Sweden), subsidiaries in 8 countries (Spain, France, Portugal, Belgium, Sweden, the United Kingdom, Poland and Singapore), and 155 business partners in more than 70 countries.

Business Activities

Active Pharmaceutical Ingredients (APIs)

ManufacturerDistributorContract ManufacturerClinical Trial OrganizationEquipment SupplierLicensed ManufacturerHealthcare FacilityLicensing Partner

Contract & Outsourcing Services

ManufacturerDistributorContract ManufacturerClinical Trial OrganizationEquipment SupplierLicensed ManufacturerHealthcare FacilityLicensing Partner

Finished Dosage Forms

ManufacturerDistributorContract ManufacturerClinical Trial OrganizationEquipment SupplierLicensed ManufacturerHealthcare FacilityLicensing Partner

Manufacturing Equipment & Utilities

ManufacturerDistributorContract ManufacturerClinical Trial OrganizationEquipment SupplierLicensed ManufacturerHealthcare FacilityLicensing Partner

ATC (Anatomical Therapeutic Chemical) Classification

ManufacturerDistributorContract ManufacturerClinical Trial OrganizationEquipment SupplierLicensed ManufacturerHealthcare FacilityLicensing Partner

Innovator APIs

ManufacturerDistributorContract ManufacturerClinical Trial OrganizationEquipment SupplierLicensed ManufacturerHealthcare FacilityLicensing Partner

Certifications

Other

GMP

ISO

Proofs

CPHI Milan 2026
CPHI Milan 2026
10/2026 – 10/2026

CPHI Milan 2026

Location
Fiera Milano, Italy
Filters:
Sort by:

    No comments available.